SMEAL WIKI

Cost-effectiveness of sofosbuvir-based treatments for chronic hepatitis C in the US

Sai Zhang, Nathaniel D. Bastian, Paul M. Griffin
Year2015
VenueBMC Gastroenterology
Typearticle
Citations55
DOI10.1186/s12876-015-0320-4
OpenAlexW1910533708

Topics

Hepatitis C virus researchSofosbuvirMedicineRibavirinTelaprevirCirrhosis